Expenses. Selling, general and administrative expenses were $1,422,939 for the three months ended June 30, 2023, to $1,382,603 for the comparable three months in the prior year. As a percentage of net sales, these expenses decreased to 21.2% for the three-month period ended June 30, 2023, from 29.8% for the 2022 period. These expenses decreased as a percentage of net sales since selling, general, and administrative expenses do not fluctuate in direct proportion to sales. Certain expenses, individually immaterial, including selling administrative expense, insurance expense, and audit and accounting expense increased as a dollar amount from the prior year’s comparable period, while expenses attributable to a potential merger in the prior year’s comparable period decreased as a dollar amount.
Engineering and Product Development. Engineering and product development expenses were $64,963 for the three-month period ended June 30, 2023, compared to $89,262 for the comparable quarter of the prior year.
Interest Expense. Our interest expense was $50,496 for the quarter ended June 30, 2023, compared to interest expense of $55,496 for the quarter ended June 30, 2022. Interest expense is dependent upon the total amounts borrowed from the Factor and interest rates during the period as compared to the corresponding period of the prior year.
Net Income (Loss). We reported net income of $165,130 for the quarter ended June 30, 2023, compared to a net loss of $106,138 for the corresponding quarter of the prior fiscal year, a $271,268 (255.6%) increase in net income. The primary reason for the increase in the net income is that supply chain disruptions have been minimized by fulfilling orders from existing inventory during the three months ended June 30, 2023, resulting in higher sales.
Operating activities provided cash of $178,366 for the three months ended June 30, 2023. This was primarily due to a decrease in inventories, prepaid expenses and other of $1,070,043, and net income of $165,130, and offset by an increase in accounts receivable and amount due from factor of $1,005,999, and a decrease in accounts payable and accrued expenses of $54,123. Operating activities used cash of $562,395 for the three months ended June 30, 2022. This was primarily due to a increase in inventories, prepaid expenses and other of $574,655, and a decrease in accounts payable and accrued expenses of $318,965, a net loss of $106,138, and offset by a decrease in accounts receivable and due from factor of $432,250.
There were no investing activities for the three months ended June 30, 2023, or 2022.
Financing activities used cash of $89,051 during the three months ended June 30, 2023, which is comprised of advances net of borrowings from the factor. Financing activities provided cash of $379,541 during the three months ended June 30, 2022, which is comprised of borrowings net of advances from the factor of $679,541, and repayment of a note payable to Eyston Company Ltd. of $300,000 for the three months ended June 30, 2022.
Liquidity and Capital Resources
The Company believes its balances of cash, funds available to borrow under the terms of its factoring agreement, and cash generated by ongoing operations will be sufficient to satisfy its cash requirements over the next twelve months and beyond. The Company’s contractual cash requirements have not changed materially since it filed its Form 10-K for the period ended March 31, 2023.
CRITICAL ACCOUNTING POLICIES
In the notes to the consolidated financial statements, and in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Form 10-K, we have disclosed those accounting policies that we consider to be significant in determining our results of Operations and financial condition. There have been no material changes to those policies that we consider to be significant since the filing of our Form 10-K. The accounting principles used in preparing our unaudited condensed consolidated financial statements conform in all material respects to accounting principles generally accepted in the United States of America.
ITEM 4.CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain a system of disclosure controls and procedures (as such item is defined in Rules 13a – 15(e) and 15d – 15(e) of the Exchange Act) that is designed to provide reasonable assurance that information, which is required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time